Illustration of a clinic building (not a photo of the practice)
Illustration

Mark A. Boissonneault, DPM

Podiatry in Reisterstown, MD

  • Enrolled in Medicare
  • 6 years since graduation
  • Public record — not managed by the clinician

About Dr. Mark Boissonneault

Dr. Mark Boissonneault is a clinician specializing in podiatry practicing in Reisterstown, MD, a graduate of William M. Scholl College of Podiatric Medicine (2020). Treated 171 Medicare patients in 2024.

Provider details

SpecialtyPodiatryOther podiatry doctors in Reisterstown
CredentialsDPM
EducationWilliam M. Scholl College of Podiatric Medicine, 2020CMS Doctors and Clinicians
GenderMale
NPI number1508493248National Provider Identifier (CMS NPPES), issued March 2020
MedicareEnrolled in MedicareCMS Doctors and Clinicians

Dr. Mark Boissonneault's specialties and state licenses

  • Podiatrist Primary
    License: MD 01789

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Where Dr. Mark Boissonneault practices

  • Practice address 4 Glyndon Dr, Suite 2a, Reisterstown, MD 21136 Directions

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Dr. Mark Boissonneault's Medicare patients and services (2024)

171Medicare patients
478services billed
76average patient age
49%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Removal of fingernails or toenails, 6 or more nails130$46.30
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more119$94.69
Removal of noncancer thickened skin growth, 2-4 growths79$85.42
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more35$116.51
X-ray of foot, minimum of 3 views25$36.20
Removal of noncancer thickened skin growth, 1 growth19$75.13

Common conditions among these patients

  • High cholesterol75%
  • High blood pressure75%
  • Arthritis47%
  • Diabetes46%
  • Chronic kidney disease30%
  • Ischemic heart disease29%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Payments from drug and device companies to Dr. Mark Boissonneault (2025)

$938.72 in 27 general payments reported in 2025.

TypePaymentsAmount
Food and beverage26$779.39
Travel and lodging1$159.33

Paying companies: Stryker Corporation ($345.17), Treace Medical Concepts, Inc. ($329.89), Amgen Inc. ($224.80), Smith+Nephew, Inc. ($38.86).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Questions about Dr. Mark Boissonneault

What kind of clinician is Dr. Mark Boissonneault?

Dr. Mark Boissonneault is listed as a clinician specializing in podiatry.

Where does Dr. Mark Boissonneault practice?

The main practice address at 4 Glyndon Dr, Suite 2a, Reisterstown, MD 21136.

What is the NPI number of Dr. Mark Boissonneault?

The National Provider Identifier is 1508493248.

Does Dr. Mark Boissonneault accept Medicare?

CMS lists this clinician as enrolled in Medicare. Ask the office about assignment and your plan.

Where did Dr. Mark Boissonneault go to medical school?

William M. Scholl College of Podiatric Medicine, graduating in 2020.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2024-08-26
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

0 clinics selected Compare